Panion & Bf Biotech Inc. - Laporan Laba Rugi (TTM)

Panion & Bf Biotech Inc.
TW ˙ TWSE
NT$ 73.20 ↑0.40 (0.55%)
2025-09-05
BAHAGING PRESYO
Laporan Laba Rugi (TTM)

Laporan Laba Rugi Panion & Bf Biotech Inc. menunjukkan perubahan pendapatan dan pengeluaran selama periode waktu tertentu. Data Laporan Laba Rugi meliputi Penjualan dan Pendapatan, Laba Kotor, Penelitian dan Pengembangan (R&D), Beban Penjualan, Umum dan Administrasi (SG&A), Laba Operasi, Beban Pajak Penghasilan, Beban Bunga, Pendapatan Non-Operasi, Laba per Saham (EPS), dan Saham yang Beredar.

Semua angka adalah kelipatan 1,000,000 kecuali unit per saham.

2020
09-30
2020
12-31
2021
03-31
2021
06-30
2021
09-30
2021
12-31
2022
03-31
2022
06-30
2022
09-30
2022
12-31
2023
03-31
2023
06-30
2023
09-30
2023
12-31
2024
03-31
2024
06-30
2024
09-30
2024
12-31
2025
03-31
2025
06-30
Revenue 1,521 1,569 1,602 1,807 1,950 1,901 1,982 2,263 2,396 2,399 2,353 2,008 1,821 1,882 1,973 2,009 2,036 2,030 2,012 2,009
Change (%) 3.10 2.13 12.76 7.93 -2.49 4.24 14.21 5.84 0.13 -1.92 -14.65 -9.31 3.35 4.83 1.84 1.32 -0.30 -0.88 -0.13
% of Revenue 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00
Cost Of Sales 731 755 789 884 959 989 1,005 1,090 1,143 1,080 1,051 937 846 907 936 951 968 959 960 954
Change (%) 3.24 4.53 12.05 8.47 3.17 1.60 8.46 4.83 -5.47 -2.68 -10.82 -9.72 7.24 3.17 1.58 1.82 -0.93 0.01 -0.55
% of Revenue 48.04 48.11 49.24 48.92 49.17 52.02 50.71 48.16 47.70 45.03 44.68 46.68 46.47 48.22 47.46 47.34 47.57 47.27 47.70 47.49
Gross Operating Profit 791 814 813 923 991 912 977 1,173 1,253 1,319 1,301 1,071 975 974 1,037 1,058 1,067 1,070 1,052 1,055
Change (%) 2.97 -0.09 13.46 7.41 -7.97 7.09 20.12 6.78 5.24 -1.30 -17.74 -8.95 -0.03 6.38 2.08 0.88 0.27 -1.69 0.25
% of Revenue 51.96 51.89 50.76 51.08 50.83 47.98 49.29 51.84 52.30 54.97 55.32 53.32 53.53 51.78 52.54 52.66 52.43 52.73 52.30 52.51
SG&A 546 564 563 595 606 589 608 629 657 656 645 609 578 601 617 612 619 618 607 611
Change (%) 3.23 -0.03 5.58 1.90 -2.83 3.15 3.51 4.38 -0.06 -1.64 -5.63 -5.06 3.85 2.82 -0.94 1.27 -0.25 -1.76 0.59
% of Revenue 35.89 35.93 35.17 32.93 31.09 30.98 30.66 27.79 27.41 27.35 27.43 30.33 31.76 31.91 31.30 30.44 30.43 30.44 30.17 30.39
R&D 113 127 143 150 165 158 155 183 193 248 278 268 269 217 218 243 229 237 229 196
Change (%) 12.51 12.87 4.59 9.79 -4.20 -1.60 18.10 5.28 28.78 11.77 -3.66 0.65 -19.41 0.33 11.67 -5.68 3.28 -3.26 -14.39
% of Revenue 7.42 8.10 8.95 8.30 8.44 8.30 7.83 8.10 8.06 10.36 11.81 13.33 14.79 11.53 11.04 12.10 11.27 11.67 11.39 9.76
OpEx 1,400 1,464 1,515 1,648 1,748 1,736 1,768 1,902 1,992 1,985 1,974 1,814 1,694 1,725 1,772 1,816 1,827 1,824 1,805 1,761
Change (%) 4.55 3.44 8.79 6.12 -0.72 1.84 7.61 4.72 -0.37 -0.53 -8.12 -6.62 1.84 2.69 2.50 0.62 -0.17 -1.01 -2.47
% of Revenue 92.05 93.34 94.54 91.20 89.67 91.30 89.20 84.05 83.16 82.74 83.92 90.34 93.02 91.67 89.80 90.38 89.75 89.87 89.75 87.65
Operating Income 121 104 88 159 201 165 214 361 403 414 378 194 127 157 201 193 209 206 206 248
Change (%) -13.65 -16.22 81.56 26.68 -17.89 29.43 68.73 11.72 2.61 -8.60 -48.75 -34.44 23.37 28.36 -3.94 7.94 -1.47 0.26 20.32
% of Revenue 7.95 6.66 5.46 8.80 10.33 8.70 10.80 15.95 16.84 17.26 16.08 9.66 6.98 8.33 10.20 9.62 10.25 10.13 10.25 12.35
Interest Expense -3 -4 -8 -12 -15 -15 -13 -10 -8 -8 -7 -9 -10 -11 -13 -14 -15 -15 -15 -15
Change (%) 67.04 83.07 46.32 26.52 -2.98 -12.74 -22.33 -23.59 -0.22 -3.68 16.71 17.27 13.57 12.36 8.54 5.08 3.21 0.83 -1.23
% of Revenue -0.18 -0.28 -0.51 -0.66 -0.78 -0.77 -0.65 -0.44 -0.32 -0.32 -0.31 -0.42 -0.55 -0.60 -0.65 -0.69 -0.71 -0.74 -0.75 -0.74
Net Income 47 28 2 84 147 104 169 256 274 182 165 22 -49 77 98 101 121 125 109 127
Change (%) -40.90 -91.37 3,402.91 74.42 -29.01 61.63 51.47 7.08 -33.38 -9.25 -86.98 -326.24 -258.37 27.42 2.92 19.81 2.63 -12.58 16.42
% of Revenue 3.10 1.78 0.15 4.67 7.54 5.49 8.51 11.29 11.43 7.60 7.03 1.07 -2.68 4.10 4.99 5.04 5.96 6.14 5.41 6.31

Source: Capital IQ

Fintel data has been cited in the following publications:
Daily Mail Fox Business Business Insider Wall Street Journal The Washington Post Bloomberg Financial Times Globe and Mail
NASDAQ.com Reuters The Guardian Associated Press FactCheck.org Snopes Politifact
Federal Register The Intercept Forbes Fortune Magazine TheStreet Time Magazine Canadian Broadcasting Corporation International Business Times
Cambridge University Press Investopedia MarketWatch NY Daily News Entrepreneur Newsweek Barron's El Economista